Guggenheim Capital’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.44M | Sell |
6,346
-3,374
| -35% | -$1.9M | 0.02% | 559 |
|
|
2026
Q1 | $5.76M | Buy |
9,720
+1,564
| +19% | +$779K | 0.04% | 412 |
|
|
2025
Q4 | $3.97M | Buy |
8,156
+968
| +13% | +$451K | 0.03% | 489 |
|
|
2025
Q3 | $3.01M | Sell |
7,188
-3,358
| -32% | -$1.13M | 0.02% | 574 |
|
|
2025
Q2 | $3.03M | Sell |
10,546
-491
| -4% | -$147K | 0.02% | 537 |
|
|
2025
Q1 | $3.4M | Buy |
11,037
+597
| +6% | +$205K | 0.03% | 515 |
|
|
2024
Q4 | $3.68M | Sell |
10,440
-4,938
| -32% | -$1.82M | 0.03% | 498 |
|
|
2024
Q3 | $5.51M | Sell |
15,378
-10,571
| -41% | -$3.57M | 0.04% | 498 |
|
|
2024
Q2 | $8.27M | Sell |
25,949
-3,221
| -11% | -$852K | 0.06% | 358 |
|
|
2024
Q1 | $6.7M | Buy |
29,170
+5,975
| +26% | +$1.35M | 0.05% | 453 |
|
|
2023
Q4 | $5.1M | Sell |
23,195
-6,167
| -21% | -$1.42M | 0.04% | 523 |
|
|
2023
Q3 | $6.63M | Buy |
29,362
+164
| +0.6% | +$37.8K | 0.06% | 403 |
|
|
2023
Q2 | $6.45M | Buy |
29,198
+4,797
| +20% | +$1.06M | 0.05% | 442 |
|
|
2023
Q1 | $5.46M | Sell |
24,401
-581
| -2% | -$143K | 0.05% | 492 |
|
|
2022
Q4 | $6.95M | Buy |
24,982
+2,442
| +11% | +$616K | 0.06% | 405 |
|
|
2022
Q3 | $4.72M | Sell |
22,540
-6,668
| -23% | -$1.49M | 0.04% | 522 |
|
|
2022
Q2 | $6.88M | Sell |
29,208
-7,237
| -20% | -$1.47M | 0.05% | 420 |
|
|
2022
Q1 | $6.54M | Sell |
36,445
-50
| -0.1% | -$9.53K | 0.04% | 549 |
|
|
2021
Q4 | $7.89M | Buy |
36,495
+287
| +0.8% | +$56.3K | 0.04% | 509 |
|
|
2021
Q3 | $6.68M | Sell |
36,208
-897
| -2% | -$177K | 0.04% | 540 |
|
|
2021
Q2 | $6.66M | Sell |
37,105
-1,688
| -4% | -$321K | 0.04% | 558 |
|
|
2021
Q1 | $6.49M | Buy |
38,793
+478
| +1% | +$79.7K | 0.04% | 519 |
|
|
2020
Q4 | $5.82M | Sell |
38,315
-1,771
| -4% | -$232K | 0.04% | 519 |
|
|
2020
Q3 | $4.05M | Buy |
40,086
+4,495
| +13% | +$493K | 0.03% | 615 |
|
|
2020
Q2 | $4.31M | Sell |
35,591
-24,458
| -41% | -$2.75M | 0.03% | 583 |
|
|
2020
Q1 | $5.69M | Sell |
60,049
-9,027
| -13% | -$858K | 0.06% | 398 |
|
|
2019
Q4 | $6.08M | Buy |
69,076
+14,980
| +28% | +$1.32M | 0.05% | 526 |
|
|
2019
Q3 | $4.31M | Sell |
54,096
-5,387
| -9% | -$434K | 0.03% | 665 |
|
|
2019
Q2 | $4.64M | Sell |
59,483
-8,408
| -12% | -$786K | 0.04% | 648 |
|
|
2019
Q1 | $7.97M | Buy |
67,891
+11,838
| +21% | +$1.38M | 0.06% | 380 |
|
|
2018
Q4 | $6.1M | Sell |
56,053
-1,847
| -3% | -$214K | 0.05% | 464 |
|
|
2018
Q3 | $7.4M | Sell |
57,900
-20,779
| -26% | -$2.57M | 0.05% | 486 |
|
|
2018
Q2 | $8.9M | Sell |
78,679
-27,370
| -26% | -$3.01M | 0.06% | 379 |
|
|
2018
Q1 | $11.9M | Buy |
106,049
+2,818
| +3% | +$358K | 0.03% | 618 |
|
|
2017
Q4 | $15.3M | Buy |
103,231
+12,694
| +14% | +$1.61M | 0.04% | 577 |
|
|
2017
Q3 | $10.6M | Buy |
90,537
+6,941
| +8% | +$886K | 0.02% | 658 |
|
|
2017
Q2 | $10.8M | Buy |
83,596
+26,564
| +47% | +$3.31M | 0.03% | 648 |
|
|
2017
Q1 | $7.72M | Buy |
57,032
+11,463
| +25% | +$1.74M | 0.02% | 780 |
|
|
2016
Q4 | $6.54M | Sell |
45,569
-75,756
| -62% | -$9.67M | 0.02% | 864 |
|
|
2016
Q3 | $14.3M | Sell |
121,325
-17,441
| -13% | -$2.1M | 0.04% | 565 |
|
|
2016
Q2 | $14.7M | Sell |
138,766
-8,155
| -6% | -$910K | 0.05% | 560 |
|
|
2016
Q1 | $16.4M | Sell |
146,921
-18,578
| -11% | -$2.35M | 0.05% | 575 |
|
|
2015
Q4 | $25.9M | Sell |
165,499
-72,639
| -31% | -$10.6M | 0.08% | 474 |
|
|
2015
Q3 | $31.3M | Buy |
238,138
+5,227
| +2% | +$838K | 0.1% | 366 |
|
|
2015
Q2 | $40.5M | Sell |
232,911
-1,113
| -0.5% | -$200K | 0.1% | 352 |
|
|
2015
Q1 | $40.4M | Buy |
234,024
+4,868
| +2% | +$742K | 0.1% | 380 |
|
|
2014
Q4 | $29.7M | Sell |
229,156
-46,100
| -17% | -$5.94M | 0.07% | 484 |
|
|
2014
Q3 | $35.4M | Sell |
275,256
-7,722
| -3% | -$796K | 0.08% | 386 |
|
|
2014
Q2 | $25M | Sell |
282,978
-43,386
| -13% | -$4.17M | 0.06% | 558 |
|
|
2014
Q1 | $30.7M | Buy |
326,364
+11,172
| +4% | +$1.14M | 0.09% | 369 |
|
|
2013
Q4 | $35.6M | Sell |
315,192
-21,456
| -6% | -$1.93M | 0.11% | 243 |
|
|
2013
Q3 | $26.5M | Sell |
336,648
-5,474
| -2% | -$400K | 0.1% | 281 |
|
|
2013
Q2 | $22.5M | Buy |
+342,122
| New | +$22M | 0.09% | 279 |
|
Other funds holding UTHR
ACA
JT
Guggenheim Capital's UTHR Position: Q2 2026 in Review
Guggenheim Capital reduced its United Therapeutics (UTHR) stake by 35% in Q2 2026, selling an estimated $1.9M and leaving 6,346 shares worth $3.44M. The position accounts for 0.02% of the portfolio, ranked #559.
Guggenheim Capital first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $40.5M in Q2 2015. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Guggenheim Capital held 6,346 shares of United Therapeutics worth $3.44M as of Q2 2026.
- Guggenheim Capital sold 3,374 United Therapeutics shares in Q2 2026, an estimated $1.9M.
- United Therapeutics made up 0.02% of Guggenheim Capital's portfolio in Q2 2026, its #559 holding.
- Guggenheim Capital first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Guggenheim Capital's United Therapeutics position peaked at $40.5M in Q2 2015.
- 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.